References
- Shtrasburg S, Pras M, Dolitzky M, Pariente C, Gal R, Livneh A. Pregnancy and amyloidosis: II. Suppression of amyloidogenesis during pregnancy. J Lab Clin Med 2000;136:314–19
- Cabili S, Livneh A, Zemer D, Rabinovitch O, Pras M. The effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. Am J Reprod Immunol 1992;28:243–4
- Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Eng J Med 1986;314:1001–5
- Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 2011;29:1924–33
- Kumar S, Dispenzieri A, Katzmann JA, Larson DR, Colby CL, Lacy MQ, Hayman SR, et al Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features. Blood 2010;116:5126–9
- Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, Greipp PR, et al Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004;22:3751–7
- Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631–44